393 related articles for article (PubMed ID: 21292262)
21. Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus.
Pech O; Behrens A; May A; Nachbar L; Gossner L; Rabenstein T; Manner H; Guenter E; Huijsmans J; Vieth M; Stolte M; Ell C
Gut; 2008 Sep; 57(9):1200-6. PubMed ID: 18460553
[TBL] [Abstract][Full Text] [Related]
22. The safety and efficacy of radiofrequency ablation following endoscopic submucosal dissection for Barrett's neoplasia.
Subramaniam S; Kandiah K; Chedgy F; Meredith P; Longcroft-Wheaton G; Bhandari P
Dis Esophagus; 2018 Mar; 31(3):. PubMed ID: 29211875
[TBL] [Abstract][Full Text] [Related]
23. Endotherapy versus surgery for early neoplasia in Barrett's esophagus: a meta-analysis.
Wu J; Pan YM; Wang TT; Gao DJ; Hu B
Gastrointest Endosc; 2014 Feb; 79(2):233-241.e2. PubMed ID: 24079410
[TBL] [Abstract][Full Text] [Related]
24. Stepwise radical endoscopic resection for Barrett's esophagus with early neoplasia: report on a Brussels' cohort.
Pouw RE; Peters FP; Sempoux C; Piessevaux H; Deprez PH
Endoscopy; 2008 Nov; 40(11):892-8. PubMed ID: 19009481
[TBL] [Abstract][Full Text] [Related]
25. Multicenter, randomized, controlled trial of confocal laser endomicroscopy assessment of residual metaplasia after mucosal ablation or resection of GI neoplasia in Barrett's esophagus.
Wallace MB; Crook JE; Saunders M; Lovat L; Coron E; Waxman I; Sharma P; Hwang JH; Banks M; DePreville M; Galmiche JP; Konda V; Diehl NN; Wolfsen HC
Gastrointest Endosc; 2012 Sep; 76(3):539-47.e1. PubMed ID: 22749368
[TBL] [Abstract][Full Text] [Related]
26. Radiofrequency ablation for the endoscopic eradication of esophageal squamous high grade intraepithelial neoplasia and mucosal squamous cell carcinoma.
van Vilsteren FG; Alvarez Herrero L; Pouw RE; ten Kate FJ; Visser M; Seldenrijk CA; van Berge Henegouwen MI; Weusten BL; Bergman JJ
Endoscopy; 2011 Apr; 43(4):282-90. PubMed ID: 21455869
[TBL] [Abstract][Full Text] [Related]
27. Improvement over time in outcomes for patients undergoing endoscopic therapy for Barrett's oesophagus-related neoplasia: 6-year experience from the first 500 patients treated in the UK patient registry.
Haidry RJ; Butt MA; Dunn JM; Gupta A; Lipman G; Smart HL; Bhandari P; Smith L; Willert R; Fullarton G; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Kapoor N; Hoare J; Narayanasamy R; Ang Y; Veitch A; Ragunath K; Novelli M; Lovat LB;
Gut; 2015 Aug; 64(8):1192-9. PubMed ID: 25539672
[TBL] [Abstract][Full Text] [Related]
28. Outcomes from a prospective trial of endoscopic radiofrequency ablation of early squamous cell neoplasia of the esophagus.
Bergman JJ; Zhang YM; He S; Weusten B; Xue L; Fleischer DE; Lu N; Dawsey SM; Wang GQ
Gastrointest Endosc; 2011 Dec; 74(6):1181-90. PubMed ID: 21839994
[TBL] [Abstract][Full Text] [Related]
29. Liquid nitrogen spray cryotherapy-based multimodal endoscopic management of dysplastic Barrett's esophagus and early esophageal neoplasia: retrospective review and long-term follow-up at an academic tertiary care referral center.
Kaul V; Bittner K; Ullah A; Kothari S
Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31909783
[TBL] [Abstract][Full Text] [Related]
30. Endoscopic ablation of Barrett's neoplasia with a new focal radiofrequency device: initial experience with the Halo60.
Allen B; Kapoor N; Willert R; McEwan H; Fullarton G; Penman I
Endoscopy; 2012 Jul; 44(7):707-10. PubMed ID: 22723187
[TBL] [Abstract][Full Text] [Related]
31. Long-term outcomes of patients with Barrett's esophagus and high-grade dysplasia or early cancer treated with endoluminal therapies with intention to complete eradication.
Guarner-Argente C; Buoncristiano T; Furth EE; Falk GW; Ginsberg GG
Gastrointest Endosc; 2013 Feb; 77(2):190-9. PubMed ID: 23317687
[TBL] [Abstract][Full Text] [Related]
32. A simplified regimen for focal radiofrequency ablation of Barrett's mucosa: a randomized multicenter trial comparing two ablation regimens.
van Vilsteren FG; Phoa KN; Alvarez Herrero L; Pouw RE; Sondermeijer CM; Visser M; Ten Kate FJ; van Berge Henegouwen MI; Weusten BL; Schoon EJ; Bergman JJ
Gastrointest Endosc; 2013 Jul; 78(1):30-8. PubMed ID: 23528655
[TBL] [Abstract][Full Text] [Related]
33. Radiofrequency ablation of Barrett's esophagus: short-term results.
Eldaif SM; Lin E; Singh KA; Force SD; Miller DL
Ann Thorac Surg; 2009 Feb; 87(2):405-10; discussion 410-1. PubMed ID: 19161747
[TBL] [Abstract][Full Text] [Related]
34. Circumferential location predicts the risk of high-grade dysplasia and early adenocarcinoma in short-segment Barrett's esophagus.
Kariyawasam VC; Bourke MJ; Hourigan LF; Lim G; Moss A; Williams SJ; Fanning SB; Chung AM; Byth K
Gastrointest Endosc; 2012 May; 75(5):938-44. PubMed ID: 22381529
[TBL] [Abstract][Full Text] [Related]
35. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry.
Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB
Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159
[TBL] [Abstract][Full Text] [Related]
36. Ablation of residual Barrett's epithelium after endoscopic resection: a randomized long-term follow-up study of argon plasma coagulation vs. surveillance (APE study).
Manner H; Rabenstein T; Pech O; Braun K; May A; Pohl J; Behrens A; Vieth M; Ell C
Endoscopy; 2014 Jan; 46(1):6-12. PubMed ID: 24353120
[TBL] [Abstract][Full Text] [Related]
37. Radiofrequency ablation for Barrett's esophagus-related neoplasia.
Krajciova J; Vackova Z; Spicak J; Martinek J
Minerva Chir; 2018 Aug; 73(4):366-377. PubMed ID: 29806757
[TBL] [Abstract][Full Text] [Related]
38. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective.
Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK
Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715
[TBL] [Abstract][Full Text] [Related]
39. Simplified protocol for focal radiofrequency ablation using the HALO90 device: short-term efficacy and safety in patients with dysplastic Barrett's esophagus.
Künzli HT; Schölvinck DW; Phoa KN; Schoon EJ; Houben MH; Bergman JJ; Weusten BL
Endoscopy; 2015 Jul; 47(7):592-7. PubMed ID: 25675174
[TBL] [Abstract][Full Text] [Related]
40. One-step circumferential endoscopic mucosal cap resection of Barrett's esophagus with early neoplasia.
Conio M; Fisher DA; Blanchi S; Ruggeri C; Filiberti R; Siersema PD
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):81-91. PubMed ID: 23856637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
